Journal issue overview 1/2019 Athero Review

7

Nutraceuticals with hypolipidemic effect in clinical practice: a summary statement of the International expert panel of lipidologists prepared by the committee of the Czech society for atherosclerosis

Michal Vrablík, Jan Piťha, Vladimír Bláha, Renata Cífková, Tomáš Freiberger, David Karásek, Pavel Kraml, Hana Rosolová, Vladimír Soška, Tomáš Štulc, Zuzana Urbanová

19

An initiative to establish apheresis centers: indications for and performance of lipoprotein apheresis in the Czech Republic

Vladimír Bláha, Milan Bláha, Jan Piťha, Michal Vrablík

30

Lysosomal acid lipase deficiency in differential diagnosis of familial hypercholesterolemia

Zuzana Urbanová, Věra Malinová

35

Therapy of dyslipidaemia in patient with muscular dystrophy: case report

Ľubica Cibičková, David Karásek

38

Severe mixed dyslipidemia as a manifestation of hematological disease: case report

Martin Šatný, Michal Vrablík, Janka Franeková, Jan Kovář

44

Psoriasis as a risk factor for cardiovascular events: case report

Branislav Vohnout, Jana Lisičanová, Andrea Havranová

49

Intensive management of dyslipidemia in very high-risk patients with PCSK9 inhibitors

Viera Doničová, Martina Gáborová

53

The effect of alirocumab on cardiovascular events: What did the ODYSSEY OUTCOMES Trial show?

Petr Ošťádal

Athero Review - Issue 1/2019

Guidelines

Reviews

clinical studies

Athero Review